At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96 enrolled
Drug / intervention
CI532 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults
In Brief
A clinical study evaluating CI532 and Nucleus 7 for Hearing Loss, Sensorineural. Completed, enrolled 96 participants across 10 sites.
Detailed Summary
The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartFeb 2017
Primary CompletionDec 2018
Study CompletionMar 2020
TodayJul 2026
First PostedJan 2, 2017
Enrollment StartFeb 15, 2017
Primary CompletionDec 3, 2018
Study CompletionMar 6, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.5 years ago
Interventions
CI532device
Cochlear implant
Nucleus 7device
Sound processor